Clean Science and Technology

CLEAN is in a confirmed bearish trend across daily, weekly, and monthly timeframes as of 2026-11-06. The stock closed at ₹670.00, trading below all key moving averages (EMA/SMA 20/50/200) and the Supertrend indicator. Trend strength is established on daily (ADX 28.5) and monthly (ADX 38.08) charts, with Minus DI significantly outpacing Plus DI, indicating sustained selling pressure.

Price positioning is near multi-period lows: +13.8% above the 20-day low, +10.9% above the 50-day low, and +6.1% above the 252-day low. Recent price action shows weakness, including an extreme volume-driven drop on 2026-11-02 (-7.4%) and a moderate downward gap on 2026-11-06 (-1.3%). An active 'Inside Bar' pattern on the daily chart suggests consolidation or indecision following the sharp decline.

Risk metrics are elevated, with annualized volatility at +33.6% and ATR at 4.04%. The stock has suffered a current drawdown of -56.8%, nearing its maximum historical drawdown of -57.6%. Immediate resistance lies at the pivot level of ₹673.92 (+0.58%), while support is found at ₹665.73 (-0.64%).

The setup remains bearish until price closes decisively above the nearest resistance at ₹673.92 and reclaims short-term moving averages. Failure to hold above ₹665.73 could expose further downside toward ₹652.77.

On 2 November 2026, two major Indian brokerages issued divergent views on Clean Science & Technology, highlighting a split in analyst sentiment. Motilal Oswal assigned a 'Neutral' rating with a price target of ₹770, while Prabhudas Lilladher recommended an 'Accumulate' stance with a slightly lower target of ₹769. These ratings suggest that while some analysts see value at current levels (Prabhudas Lilladher), others perceive limited upside or higher risk relative to the fair value estimate (Motilal Oswal). The narrow range between the two targets (₹769–₹770) indicates a consensus on the stock's valuation floor, despite differing tactical recommendations. Investors should monitor these external opinions as conditional signals rather than factual outcomes, noting that brokerage views are based on specific models and assumptions not disclosed in the provided summaries.

Clean Science and Technology Limited’s Board approved unaudited financial results for the half-year ended September 30, 2026, on October 31, 2026. Consolidated revenue from operations reached ₹8,153.35 million with a profit before tax of ₹1,714.37 million. For the quarter ended September 30, 2026 (Q2 FY27), consolidated revenues were ₹295–₹299 crore, representing a 22–23% year-over-year increase, while Profit After Tax remained stable at ₹56 crore against ₹55 crore in the prior year period.

Management highlighted a fundamental shift in the HALS segment, which doubled year-on-year growth and achieved profitability. Strategic initiatives include backward integration to improve margins by 5–7%, capacity expansion from ~11,500 tons to ~12,500 tons, and capital expenditure of approximately ₹150 crore towards its subsidiary, Clean Fino Chem Ltd. (CFCL). CFCL completed advanced product trials with Geneus Chem AG, with commercialization targeted for H2 FY27. However, raw material cost increases due to Middle East tensions compressed standalone margins despite volume-led growth.

Clean Science and Technology reported a sequential revenue increase to ₹299 crore in Q2 FY2026-27, up from ₹268 crore in Q1. However, this top-line growth was accompanied by a sharp rise in expenses to ₹231 crore (from ₹193 crore), causing Profit Before Tax to fall sequentially to ₹74.4 crore from ₹97.6 crore. This margin compression is evident in the quarterly EPS decline from ₹6.9 to ₹5.24. On an annual basis, while TTM sales grew 5% to ₹1,037 crore, TTM net profit contracted by 12% to ₹233 crore, reflecting persistent profitability pressure.

Financial health remains robust with negligible borrowings (₹2 crore) and strong cash generation; CFO/EBITDA improved to 103% in FY2026. The balance sheet shows significant capital expansion, with Capital Work-in-Progress rising to ₹156 crore and total assets increasing to ₹1,920 crore as of Sep 2026. Working capital efficiency has deteriorated, with the Cash Conversion Cycle widening to 118 days in Mar 2026 from 99 days in Mar 2024, driven by higher inventory days (157 days). Promoter holding stabilized at 51.29% in Sep 2026 after a significant dilution from 74.97% in Sep 2024.

Clean Science and Technology (NSE) exhibits significant technical weakness as of November 6, 2026, with the stock trading at ₹670.00, down 1.3% from the previous close of ₹678.70. The daily trend is bearish, characterized by a Supertrend signal indicating downward pressure and negative slopes across key moving averages: the 20-day EMA slope is -38.6, the 20-day SMA slope is -35.5, and the 50-day SMA slope is -16.06. This indicates sustained selling momentum over multiple timeframes.

Performance metrics reflect substantial recent losses. The stock has declined 18.6% over the past month, 22.0% over six months, and 31.7% over the last year. Year-to-date returns stand at -22.0%, while the maximum drawdown recorded is -57.6%, with the current drawdown at -56.8%. Volatility remains elevated, with annualized volatility at +33.6% and an Average True Range (ATR) of 4.04%. Brokerage sentiment appears cautious; Motilal Oswal has assigned a neutral rating with a target of ₹770, while Prabhudas Lilladher recommends accumulating with a target of ₹769. Both targets are significantly above the current price, suggesting limited near-term upside potential relative to the current downtrend.